Zirlik, Andreas, 1974-
Zirlik, Andreas
Andreas Zirlik researcher
VIAF ID: 32901421 (Personal)
Permalink: http://viaf.org/viaf/32901421
Preferred Forms
- 100 0 _ ‡a Andreas Zirlik ‡c researcher
- 100 1 _ ‡a Zirlik, Andreas
- 100 1 _ ‡a Zirlik, Andreas
- 100 1 _ ‡a Zirlik, Andreas
-
- 100 1 _ ‡a Zirlik, Andreas ‡d 1974-
- 100 1 _ ‡a Zirlik, Andreas ‡d 1974-
-
4xx's: Alternate Name Forms (4)
5xx's: Related Names (3)
- 551 _ _ ‡a Schweinfurt ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _ ‡a Universitätsklinik für Innere Medizin ‡g Graz ‡b Klinische Abteilung für Kardiologie ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Universitätsklinikum Freiburg ‡b Klinik für Kardiologie und Angiologie I ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial | |
association of high-normal international-normalized-ratio (INR) with mortality in patients referred for coronary angiography | |
Beeinflussung inflammatorischer Signalwege als Therapieansatz der Atherosklerose | |
Cannabinoid Rezeptor 2 (CB2) moduliert nicht die Entstehung der Atherosklerose in Mäusen | |
Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range | |
CD40L and its receptors in atherothrombosis - an update | |
Circulating autoantibodies recognizing immunodominant epitopes from human apolipoprotein B associate with cardiometabolic risk factors, but not with atherosclerotic disease | |
Contribution of CD40L/Mac-1 pathway to the metabolic syndrome | |
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany | |
Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency | |
Deskriptive und funktionelle Charakterisierung der CD40L/Mac-1 Interaktion | |
Diabetes, Prädiabetes und kardiovaskuläre Erkrankungen CardioCard 2020 | |
Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis | |
Dysregulation of the mitochondrial proteome occurs in mice lacking adiponectin receptor 1 | |
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome | |
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial | |
Effects of short term adiponectin receptor agonism on cardiac function and energetics in diabetic db/db mice | |
Einfluss einer Adiponektindefizienz auf die myokardiale Substratoxidation und kardiale Kontraktionsfunktion | |
Established and emerging mechanisms of diabetic cardiomyopathy | |
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice | |
In-vitro-Darstellung von Herzkranzarterien mittels dreidimensionaler Kontrastechokardiographie | |
Inflammation in acute coronary syndrome: expression of TLR2 mRNA is increased in platelets of patients with ACS | |
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering | |
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense | |
Loss of protective autoimmunity in atherosclerosis | |
Ly6Chigh Monozyten fördern den optimalen Verlauf der biphasischen Heilung nach Herzinfarkt via Nr4a1 | |
Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe–/– mice | |
P2X4 deficiency reduces atherosclerosis and plaque inflammation in mice | |
Platelets, haemostasis and inflammation, 2017: | |
Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis | |
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile | |
Proportion of patients eligible for statin therapy substantially varies between different cardiovascular disease risk calculators and guidelines used | |
Real-time magnetic resonance imaging - guided coronary intervention in a porcine model | |
Renal denervation in high-risk patients with hypertension | |
Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort | |
Risk categorization using New American College of Cardiology / American Heart Association Guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes | |
role of tumor necrosis associated factor (TRAF)-1 in cardio-metabolic disease | |
Rolle des P2Y6 Rezeptors im Metabolischen Syndrom | |
TRAF 5 Defizienz beschleunigt die Ausbildung von Atherosklerose in Mäusen durch vermehrte Rekrutierung inflammatorischer Zellen und verstärkte Schaumzellbildung | |
TRAFIC - eine prospektive Studie zur Expression von Tumornekrosefaktor Rezeptor- assoziierten Faktoren bei Patienten mit Koronarer Herzerkrankung | |
Transcatheter and surgical aortic valve replacement in patients with previous coronary bypass grafts | |
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation |